Fresenius Medical Care AG & Co. KGaA
Open
$22.59
Prev. Close
$22.60
High
$22.60
Low
$22.59
Market Snapshot
$12.85B
11.2
0.99
$20.85B
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
emptyResult
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Recently from Cashu
Fresenius Medical Care Reports Strong Q4 Growth Driven by Innovation and Patient Care Commitment
Fresenius Medical Care's Strong Q4 Performance Underlines Commitment to Innovation and Patient Care Fresenius Medical Care AG & Co. KGaA announces significant financial results for the fourth quarter…
Fresenius Medical Care Prepares for Key Earnings Release Amid Market Anticipation and Challenges
Fresenius Medical Care Prepares for Key Earnings Release Amid Market Expectations Fresenius Medical Care AG & Co. KGaA is set to announce its quarterly earnings on February 24, 2026, an event anticipa…
Fresenius Medical Care Quarterly Update: Dialysis Volumes, Margins, Cash Flow, Capital Allocation
Fresenius Medical Care Readies Quarterly Update Operational Pulse: Dialysis Volumes, Patient Counts and Margins Fresenius Medical Care AG & Co. KGaA is due to release its quarterly results on Tuesday,…
Interwell Health Appoints Dr. Carney Taylor as CMO to Boost Value-Based Kidney Care
Interwell Health Appoints Dr. Carney Taylor to Enhance Value-Based Kidney Care Interwell Health, a prominent entity in the value-based kidney care sector and a subsidiary of Fresenius Medical Care AG…